Patent ID: 7932387

Claim:
A crystalline hydrate form of bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid] calcium salt which exhibits a characteristic X-ray powder diffraction pattern with characteristic peaks expressed in d-values (Å): 18.1 (m); 12.9 (w); 10.7 (vw); 9.5 (w); 8.6 (vs); 7.7 (w); 6.3 (vw); 5.56 (vw); 4.74 (w); 4.57 (w); 4.34 (vw); 4.24 (vw); 4.02 (vw); 3.87 (w); and 3.66 (vw); hereinafter designated as form B.